JACC: Heart Failure
| 短名 | JACC Heart Fail. |
| Journal Impact | 10.25 |
| 国际分区 | CARDIAC & CARDIOVASCULAR SYSTEMS(Q1) |
| 期刊索引 | SCI Q1中科院 1 区 |
| ISSN | 2213-1779, 2213-1787 |
| h-index | 106 |
| 国内分区 | 医学(1区)医学心脏和心血管系统(1区) |
| Top期刊 | 是 |
JACC：心力衰竭发表了关于心力衰竭患者的病理生理学、诊断、治疗和护理的最重要发现。该杂志的目标是通过及时、有见地的科学交流，提高我们对疾病、临床试验、临床结果和治疗进展的理解。该杂志包含与心力衰竭相关的神经科学、肺病学、肾病学、电生理学和外科手术的跨学科关系。此外，该杂志还包括有关药物遗传学、生物标志物和代谢组学的文章。
期刊主页投稿网址| 涉及主题 | 医学内科学心脏病学心力衰竭生物病理内分泌学外科数学心理学统计射血分数放射科化学 |
| 出版信息 | 出版商: Elsevier Inc.，出版周期: ，期刊类型: journal |
| 基本数据 | 创刊年份: 2013，原创研究文献占比: 85.94%，自引率:5.80%， Gold OA占比: 61.20% |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Measures to Improve Trial Enrollment
2024-9-1
Inpatient Use of Guideline-Directed Medical Therapy During Heart Failure Hospitalizations Among Community-Based Health Systems
2024-9-1
DOAC Use in Durable Mechanical Circulatory Support
2024-9-1
Mineralocorticoid Antagonism in Heart Failure: Established and Emerging Therapeutic Role
2024-9-1
Impact of Inpatient Percutaneous Coronary Intervention Volume on 30-Day Readmissions After Acute Myocardial Infarction-Cardiogenic Shock
2024-9-1
STRONG-HF
2024-9-1
Functional Status and Quality of Life in Light-Chain Amyloidosis
2024-9-1
Full issue PDF
2024-9-1
Editorial Board/Officers
2024-9-1
Dapagliflozin in Heart Failure, Type 2 Diabetes, and Neuropathy
2024-9-1
Evaluating Mitral TEER in the Management of Moderate Secondary Mitral Regurgitation Among Heart Failure Patients
2024-9-1
Avoiding Treatment in Hospital With Subcutaneous Furosemide for Worsening Heart Failure
2024-9-1
How Many Slices Can We Get From the Shock Pie?
2024-9-1
Sacubitril/Valsartan Versus Enalapril in Chronic Chagas Cardiomyopathy
2024-8-1
What Drives Transplant Outcomes Following Donation After Circulatory Death
2024-8-1
GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
2024-8-1
Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure Trial
2024-8-1
Encouraging Data Encourage More Research on Optimal Medical Therapy for Patients With HFrEF
2024-8-1
Vericiguat, Diabetes, and Heart Failure
2024-8-1
The Pathophysiological and Therapeutic Implications of Cardiac Light-Chain Amyloidosis Compared With Transthyretin Amyloidosis
2024-8-1
LVAD Weaning
2024-8-1
Seated Pulmonary Artery Pressure Monitoring in Patients With Heart Failure
2024-8-1
Race in Heart Failure: A Pooled Participant-Level Analysis of the Global PARADIGM-HF and PARAGON-HF Trials
2024-8-1
Sacubitril/Valsartan in Heart Failure and Deterioration in eGFR
2024-8-1
Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease
2024-8-1
Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction
2024-8-1
Finding a Signal in the Noise
2024-8-1
Full issue PDF
2024-8-1
Optimal Medical Therapy and Outcomes Among Patients With Chronic Heart Failure With Reduced Ejection Fraction
2024-8-1
Correction
2024-8-1
Rapid Uptitration of Guideline-Directed Medical Therapies in Acute Heart Failure With and Without Atrial Fibrillation
2024-8-1
Waiting for Godot?
2024-8-1
Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Tafamidis in Cardiac Amyloidosis
2024-8-1
Desire for Prognostic Information Among Persons With Advanced Heart Failure
2024-8-1
Immune Checkpoint Inhibitors Myocarditis
2024-8-1
Association Between Cardiovascular Health and Lifetime Risk of Heart Failure
2024-8-1
Reply
2024-8-1
Editorial Board/Officers
2024-8-1
Compensation Models in Heart Failure
2024-8-1
Maternal Bereavement and Heart Failure Risk of the Offspring
2024-8-1
Differential Association of Transthyretin Stability with Variant and Wild-Type Transthyretin Amyloid Cardiomyopathy
2024-8-1
Heart Failure Specialist Care and Long-Term Outcomes for Patients Admitted With Acute Heart Failure
2024-8-1
Natriuretic peptides, kidney function and clinical outcomes in heart failure with preserved ejection fraction
2024-8-1
Early U.S. Heart Transplant Experience With Normothermic Regional Perfusion Following Donation After Circulatory Death
2024-7-1
Looking Under the Hood of the “Good” Cholesterol
2024-7-1
Inflammation and Cardiorespiratory Fitness in HFpEF
2024-7-1
Management of Iron Deficiency in Heart Failure
2024-7-1
Health Status in Heart Failure and Cancer
2024-7-1
Optimizing Triage of Ambulatory Patients With Advanced Heart Failure
2024-7-1
No Matter the Breakdown, Heart Failure Is Costly
2024-7-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远